Understanding Refeeding Syndrome in Critically Ill Patients: A Narrative Review
Nutrients · 29.05.2025 · 17 (11) · 1866
DOI: 10.3390/nu17111866 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 29.05.2025. Verfasst von Raffaele Borriello und 8 weiteren Autor:innen. Beteiligte Einrichtung: CEMAD Digestive Diseases Center, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 0…. Hauptthemen laut MEDLINE: Refeeding Syndrome, Critical Illness. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Refeeding syndrome (RS) is defined as the spectrum of metabolic and biochemical disorders related to rapid nutritional replenishment after a prolonged period of fasting. It is caused by an abrupt shift in electrolytes and fluid among intra- and extracellular compartments, leading to metabolic disturbances like hypophosphatemia, vitamin deficiency, and fluid overload. RS often remains underdiagnosed due to variability in definition and diagnostic criteria adopted, overlapping clinical features with other complications and low awareness among clinicians. Critically ill individuals, particularly those admitted to intensive care units (ICUs), represent a cohort with peculiar features that may heighten RS risk due to their baseline frailty, frequent undernutrition, and the metabolic stress of acute illness. However, studies specifically conducted in ICU settings have yielded conflicting results regarding incidence rates, prognostic impact, and specific risk factors. Despite these differences, all evidence consistently highlights RS as a frequent and serious complication in critically ill patients. Early detection and prevention are essential, relying on prompt nutritional assessment at ICU admission, careful monitoring of serum electrolytes before and during refeeding, and a conservative caloric approach to nutrient reintroduction, alongside supportive therapy and electrolyte supplementation if RS manifestations occur. Clinicians should be aware of the significant prevalence and potential severity of RS in critically ill patients, along with the ongoing challenges related to its early recognition, prevention, and optimal nutritional management. This review aims to provide a comprehensive overview of the current knowledge on the incidence, prognostic impact, risk factors, clinical manifestations, and nutritional management of RS in critically ill patients while highlighting existing evidence gaps and key areas requiring clinical attention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CEMAD Digestive Diseases Center, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy.
- Department of Anesthesia and Intensive Care, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy.
ORCID-Profile: Antonio Gasbarrini, Maria Assunta Zocco
Zitieren
APA
Borriello, R., Esposto, G., Ainora, M. E., Podagrosi, G., Ferrone, G., Mignini, I., Galasso, L., Gasbarrini, A., & Zocco, M. A. (2025). Understanding Refeeding Syndrome in Critically Ill Patients: A Narrative Review. Nutrients, 17(11), 1866. https://doi.org/10.3390/nu17111866
Vancouver
Borriello R, Esposto G, Ainora ME, Podagrosi G, Ferrone G, Mignini I, et al. Understanding Refeeding Syndrome in Critically Ill Patients: A Narrative Review. Nutrients. 2025;17(11):1866. doi:10.3390/nu17111866
BibTeX
@article{Borriello2025,
author = {Borriello, Raffaele and Esposto, Giorgio and Ainora, Maria Elena and Podagrosi, Giorgio and Ferrone, Giuliano and Mignini, Irene and Galasso, Linda and Gasbarrini, Antonio and Zocco, Maria Assunta},
title = {Understanding Refeeding Syndrome in Critically Ill Patients: A Narrative Review},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {11},
pages = {1866},
doi = {10.3390/nu17111866}
}
EUVIMED